Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 16 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase III PZD and Total Body Irradiation Followed by Allogeneic Bone Marrow Transplantation and Prophylactic MTX for Acute Leukemia in Remission

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								NCI-D81-043-078 MDA-DT-7970


2.		Phase I-II Chemotherapy with CTX, ADR, DAG, VP-16, PZD and TZT for Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				no age specified								MAYO-750302


3.		Phase II Chemotherapy with PZD for Refractory Sarcomas and Malignant Melanomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								SEG-76MSAR0102 SEG-76MSAR206

Last Modified: 9/20/2007


4.		Phase II Chemotherapy with CTX/DTIC vs CTX/DTIC/Piperazinedione for Metastatic Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								SEG-77MEL0102 SEG-77MEL212


5.		Phase II Chemotherapy with Piperazinedione in Acute Childhood Leukemia and Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				under 18								SJCRH-PIPER-2


6.		Phase II Autologous Stem Cell Transplantation & PZD Chemotherapy plus Radiotherapy for Adult Acute Leukemia in Complete Remission and Chronic Phase Chronic Granulocytic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 to 50								MDA-DT-7524 NCI-D78-043-184


7.		Phase II Chemotherapy with Piperazinedione for a Wide Spectrum of Incurable Refractory Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				16 to 80								CENOG-7522

Last Modified: 9/19/2006


8.		Phase II Trials of 13 Additional Chemotherapeutic Agents, Alone or Combined for non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				EST-2575-II

Last Modified: 11/16/2007


9.		Phase II Chemotherapy with Piperazinedione for Advanced Gynecologic Malignancies in Women

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				GOG-26B


10.		Phase II Chemotherapy with CTX, ADR, VP-16, VCR, cis-Platinum, PZD, TZT and DAG for Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								MAYO-750305

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute